GS0051: Diagnostic biomarker reagents for medical and clinical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; biomarker assays to quantify disease activity; biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; diagnostic preparations, substances and materials; medical diagnostic test strips; diagnostic preparations for medical purposes; diagnostic agents for medical use
PM0001: NORDIC PROTEIN FINGERPRINT TECHNOLOGY
GS0421: Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to clinical trials; clinical trials; analysis of pharmacodynamic data; analysis of data relating to biomarkers; development of diagnostic preparations, equipment and tests; clinical testing services; diagnostic testing services; testing services relating to the detection and measurement of biomarkers; testing samples for the presence of biomarkers; laboratory services; medical laboratory services; research laboratory services; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research, experimentation, development, and analysis for medical and pharmaceutical research services; advice, information and assistance relating to the foregoing
Case File Event Statements
1/4/2024 - 11 months ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IBType:REPR
1/5/2024 - 11 months ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
1/9/2024 - 11 months ago
3 - APPLICATION FILING RECEIPT MAILEDType:MAFR
3/25/2024 - 9 months ago
4 - ASSIGNED TO EXAMINERType:DOCK
5/2/2024 - 7 months ago
5 - NON-FINAL ACTION WRITTENType:CNRT
5/3/2024 - 7 months ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEWType:RFCR
10/9/2024 - 2 months ago
12 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVEDType:REAP
5/9/2024 - 7 months ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IBType:RFCS
5/9/2024 - 7 months ago
7 - REFUSAL PROCESSED BY MPUType:RFRR
5/28/2024 - 6 months ago
9 - REFUSAL PROCESSED BY IBType:RFNT
10/9/2024 - 2 months ago
10 - TEAS CHANGE OF OWNER ADDRESS RECEIVEDType:COAR